|
The Science Behind Brain Death
New York Times In another way, the cases are identical: both families have been shocked to learn that a loved one was declared brain-dead — and that hospital officials defied the family’s wishes for treatment. Their wrenching stories raise questions about how brain … Caplan: The case against care for those who are brain deadNewsday Other View: Blurring the line between life and deathChippewa Herald Ethicists criticize treatment of brain-dead patientsUSA TODAY New York’s PIX11 / WPIX-TV all 14 news articles » |
Mood stabilizing drug may help treat acute kidney injury – Medical Xpress
Counsel & Heal |
Mood stabilizing drug may help treat acute kidney injury
Medical Xpress A mood stabilizer used to treat bipolar affective disorders may also help treat acute kidney injury, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings are significant because … Lithium May Help Treat Acute Kidney InjuryCounsel & Heal Lithium May Promote Recovery in Acute Kidney InjuryDoctors Lounge New ray of hope for kidney patientsIndia.Com Health Daily News & Analysis all 22 news articles » |
Lung cancer rates decline for US men, women: study – Reuters India
Lung cancer rates decline for US men, women: studyReuters IndiaThe lung cancer rate dropped by 2.6 percent per year among men and 1.1 percent per year among women, between 2005 and 2009, the Centers for Disease Control and Prevention found, using the m…
Seattle Gentics-AbbVie Deal Expanded – Zacks.com
Drug Discovery & Development |
Seattle Gentics-AbbVie Deal Expanded
Zacks.com AbbVie will pay an upfront fee of $25 million for additional rights of using Seattle Genetics’ ADC technology with AbbVie antibodies against oncology targets. Seattle Genetics could receive up to $255 million from AbbVie in the form of potential … Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with …Wall Street Journal Seattle Genetics and AbbVie Broaden Cancer PartnershipMotley Fool Seattle Genetics and AbbVie Broaden PartnershipPharmaceutical Processing |
Red Cross extending hours after blood donation shortfall – WEAU
Centralia Fireside guardRed Cross extending hours after blood donation shortfallWEAUEau Claire (WEAU) — The American Red Cross is asking for help after a long run of bad weather hurt blood donations. The organization says it was forced to cancel more …
Antipsychotic drug exhibits cancer-fighting properties – EurekAlert (press release)
|
Antipsychotic drug exhibits cancer-fighting properties
EurekAlert (press release) … results of its pioneering research and clinical trials to patients’ bedsides through five clinical centers: the Blood Disorders Center, the Brain Tumor Center, the Hematologic Malignancies Center, the Solid Tumors Center, and the Stem Cell … |
DCRC cures six blood disorders through stem cell transplant – Gulf Today
CTV News |
DCRC cures six blood disorders through stem cell transplant
Gulf Today DUBAI: The Dubai Cord Blood and Research Centre (DCRC), has succeeded in curing blood disorders in six of its stem cell transplant patients from cord blood. Awareness among parents to donate cord blood to save others’ lives is needed, according to a … BC women can donate umbilical cords to save livesNews1130 BC Women’s Hospital’s umbilical cord blood bank offers gift of lifeVancouver Sun |
Court summons Musharraf on Jan 16 to face treason charges – Chandigarh Tribune
Chandigarh Tribune |
Court summons Musharraf on Jan 16 to face treason charges
Chandigarh Tribune He said the former army chief has not undergone even an angiography since he was admitted to hospital and this proves his condition is not serious. Sheikh claimed Musharraf’s blood pressure was like that of a sportsman while the condition of his heart … Court Rejects Musharraf’s Plea to Stay SummonsOutlook Musharraf’s medical report: A second opinionNewstrack India |
CLL Trial Stopped as Ibrutinib Shows Significant Benefits – Medscape
Medscape |
CLL Trial Stopped as Ibrutinib Shows Significant Benefits
Medscape The only agent so far to have shown an early definitive overall survival benefit in CLL is rituximab (Rituxan, Genentech/Roche), and hence a combination of ibrutinib with rituximab is very appealing — and trials of this combination are in progress … J&J’s Imbruvica tops Arzerra in phase III trialPMLiVE |
What 'Brain-Dead' Means – CBS Local
|
What ‘Brain-Dead’ Means
CBS Local “Typically, brain death starts with some sort of devastating neurologic injury,” Tawil says. “That can come in many different forms.” They include traumatic brain injury, a stroke caused by a ruptured blood vessel in the brain, or if the heart has … |